The practice
About Dr. Casdorph
Dr. Casdorph's Carriculum Vitae
 About Chelation Therapy
 payment Information
Contact our office
Press releases



Office address:   1703 Termino Avenue, Suite 201
                           Long Beach, California  90804



 West Virginia University, Morgantown, 1946-1949.  A.B. degree with High Honors 1949.



 Indiana University Medical School, 1949-1953.  M.D. degree, June 15, 1953.




Internship, rotating, 1953-1954, Indiana University Medical Center, Indianapolis.

Fellowship in  Internal  Medicine, Mayo Foundation, 1954-1955 and 1957-1960,

Rochester, Minnesota.

Assistant to Staff in Cardiovascular Disease, Mayo Clinic, 1960-1961.

Ph.D. degree in Medicine, University of Minnesota, December 14, 1961.




School of Aviation Medicine, Air University, United States Air Force, October-December 1955

Recipient of Research Fellowship by National Institutes of Health for 12 months,
1959-1960 (while at Mayo Foundation, Rochester, Minnesota)

 Postdoctoral Fellowship.

Special course in Radioisotopes for licensure at Mayo Clinic, 1959.


 Captain United States Air Force Medical Corps., Flight Surgeon, 1611th USAF Disp., McGuire Air Force Base, New Jersey, April 1955- September 1957.






 Physicians License, State of Indiana, June 30, 1954.

Physicians License, State of Minnesota, February 14, 1958.

Physicians and Surgeons Certificate, State of California, October 5, 1961.

Diplomate of the American Board of Internal Medicine, September 13, 1962.



Phi Beta Kappa, 1949, West Virginia University.

\\Alpha Omega Alpha, 1953, Indiana University.

Rotary Club of Long Beach, 1963.

 Who's Who in the West, Volume 10, Chicago.
Dictionary of International Biography, 1967, 4th Edition, London.

The Blue Book, Leaders of the English Speaking World, May 1980.

Achievement Award, presented October 1980 at the Biltmore Hotel, Los Angeles,

California by American Academy of Medical Preventics at the Fall Conference on
Orthomolecular and Preventive Medicine for the 80's.




Director of Medical Education, St. Mary's Hospital of Long Beach, December 

Clinical Instructor in Medicine, UCLA Medical School, 1962-1965.

 Director, Lipid Research Foundation, 1969-1979.

Assistant Clinical Professor of Medicine, University of California, Irvine
College of Medicine, 1971-1986.

Consultant for National Heart and Lung Institute, Special Program Branch,
September 21-23, 1972 to present.

Subject matter expert, Health Learning System, Inc., Bloomfield, New Jersey,
February 22, 1973

Member of the Board of Visitors of the University of Minnesota, Study of Partial
Ileal Bypass in the Treatment of Hyperlipidemic State, June 1973.

Medical Advisor to the Administrative Law Judges, Bureau of Hearing and
Appeals, Social Security Administration, Department of Health, Education and
Welfare, P.O. Box 2518, Washington D.C. 20013, October 9, 1973.

Chief, Department of Internal Medicine, Long Beach Community Hospital,

President, 1987-1989, The American College of Advancement in Medicine.
Founded in 1972, the American College of Advancement in Medicine is a non-
profit professional membership society dedicated to educating physicians on  the
latest findings and emerging procedures in the field of Preventive and 
Therapeutic Medicine.

Appointment to Board of Governors for the National Health Federation, January 

Chairman of the Board of Governors, National Health Federation, July 2003.




Zumbro County Medical Association, 1960-1961.         

Minnesota State Medical Association, 1960-1961.

American Association for the Advancement in Science, 1960-1961.

American Medical Association, 1960-1976.  1988-1990.  2003-2004.

Los Angeles County Medical Association, 1962-1976. 1988-1990

California Medical Association, 1962-1976.  1988-1990. 2003-2004.

Society of Nuclear Medicine, June 14, 1961 to 1964.

Alumni Association of the Mayo Foundation for Medical Education and Research,
October 1962 to present.

Clinical Society, Diabetes Association of Southern California, 1963.

World Medical Association, 1963-1964.

American Diabetes Association, April 1, 1963.

Associate Fellow, American College of Cardiology, 1963-1976.

Member, Board of Directors, Long Beach Heart Association, 1963.

Member, Long Beach Heart Association, 1963 to present.

Member, American Heart Association, 1963 to present.

Member, American Federation for Clinical Research.

Member, Long Beach Society of Internal Medicine.

Member, Order of St. Luke the Physician, 1963.

Fellow, American College of Angiology, March 1964.

Fellow, American College of Physicians, April 1966 to present.

Long Beach Heart Association, Board of Directors, second appointment 1970-

Long Beach Heart Association, Executive Committee, 1970-

Affiliate of the Royal Society of Medicine, 1 Wimpole Street, London, April 3

Chairman of the Board of Governors, National Health Federation, July 2003.






1.H. R. Casdorph, Ph.D. Thesis: "Studies of Cholesterol Metabolism: Relationship of the Body, Cholesterol, Pool Size, Cholesterol Turnover, and Hepatic Synthetic Rate of Cholesterol to the Concentration of Plasma Cholesterol in the Dog." University of Minnesota, 1961.


2.H. Richard Casdorph. Can We Prevent "Heart Attacks."  The Quill. Vol. 20 No. 4:8, 1962.


3.H. Richard Casdorph.  Cholesterol Metabolism. Paper presented to students and staff of the California College of Medicine.  January 14, 1963.


4.H. Richard Casdorph, John L. Juergens, Alan L. Orvis, Charles A. Owen, Jr., Rate of Disappearance of Cholesterol -C14 from the Bloodstream of Dogs. Proc. Soc. Exper. Biol. Med. V 112, 191-194 (1963).


5.H. Richard Casdorph. The Search for a Cure for Diabetes.  Paper presented to the Long Beach District of the Diabetes Association of Southern California, March 27, 1963.


6.H. Richard Casdorph.  The Education of the Diabetic.  May 1963, Newsletter. Long Beach Lay Society of the Diabetes Association of Southern California.


 7.H. Richard Casdorph. Research in Diabetes.  Workshop in Health Education. Long Beach State College, July 5, 1963.


8.H. R. Casdorph, R. Delinger, D. Hamm, W. Olson.  "The Improved Outlook for the Diabetic."  Panel Discussion.  Long Beach Lay Society of the Diabetes Association of Southern California, September 23, 1963.


9.H. R. Casdorph. Hospital Experience with Cardiac Resuscitation. California Medicine.  April 1964. Vol. 100:248.


10.H. R. Casdorph.  Acute Uric Acid Nephropathy in Leukemia.  California Medicine.  Vol. 101:481-484.  Dec. 1964.


11.H. R. Casdorph.  Newer Concept in Coronary Heart Disease.  Downtown Lions Club of Long Beach.  April 17, 1964.


12.H. R. Casdorph, C. Brantingham, R. Schug, R.Shinook and Frederic Modern, Moderator. "What You Want to Know About Diabetes."  Panel Discussion. April 28, 1964.  Long Beach Diabetes Association.


13.H. R. Casdorph.  Fats in the Diet.  Symposium on Lipids, Atherosclerosis and Coronary Artery Disease.  Geriatrics Vol. 20: 168-171, March 1965.


14.H. R. Casdorph.  Newer Concept in Coronary Artery Disease.  Medical Times. Vol. 92-1029, October 1964.


15.Panel Discussion Long Beach Diabetes Society.  L. Modern, R. Casdorph and A.C. VanDyke, Why do Diabetics Require Different Kinds of Care?"  February 23, 1965.


16.H. R. Casdorph.  Studies of Atrial Fibrillation in a Hospital Population.  Age, Sex, Association Cardiac Disease, Mode of Therapy and Complications.  Medical Times.  Vol. 93:293, March 1965.


17.H. Richard Casdorph.  Studies of Atrial Fibrillation in a Hospital Population Part II.  Immediate and Late Results in patients converted to Regular Sinus Rhythm from Atrial Fibrillation.  Medical Times.  Vol. 93:685, June 1965.


18.H. R. Casdorph. Acute Uric Acid Nephropathy in Leukemia (Abstract).  Urology Digest.  Vol. 4:52, September 1965.


19.Address before Rancho Alamitos Rotary Club, Seal Beach, January 18, 1966. "Current Concept in Coronary Heart Disease."


20.H. R. Casdorph.  "Treatment of Angina Pectoris."  Clinical Medicine. Vol. 74:1, January 1967.


21.H. R. Casdorph, Cholestyramine, Therapy of Hypercholesteremia."  Progress in Biochemical Pharmacology, Vol.II. By Karger, in Basel.


22.H. R. Casdorph, "Treatment of Hypercholesteremia with Cholesteryramine, a Bile Acid Sequestering Resin."  Presented at the 8th Annual Meeting of the International College of Angiology in Madrid, Spain.  September 1, 1966.


23.H. R. Casdorph.  The Biologic Consequences of Hypercholesteremia in Man and its Treatment."  Angiology Vol. 18, No. 2.  February 1967.


24.H. R. Casdorph.  "Hypercholesteremia-Treatment with Cholestyramine, A Bile Acid Sequestering Resin", California Medicine.  Vol. 106:4 April 1967.


25.H. R. Casdorph. "Treatment of Hypercholesteremia."  JAMA Vol. 200:7, May 15, 1967.


26.Casdorph, H.R.,  "Treatment of Hypercholesteremia with Cholestyramine." Circulation Vol. 36, No. 4, Supplement No. 2-6, October 1967.


27.Casdorph, H. R., "Treatment of Hypercholesteremia with Cholestyramine, a Bile Acid Sequestering Resin."  Vascular Disease, Vol. 4:305-308, October 1967.


28.Casdorph, H. R., "Clinical Experience with Questran."  Presented to Mead Johnson Company, Evansville, Indiana  November 13, 1967.


29.Casdorph, H. R., "Treatment of the Hyperlipidemic States with Cholestyramine, a Bile Acid Sequestering Resin."  Presented at Milan, Italy  September 11, 1968 at the Third International Symposium on Drugs Affecting Lipid Metabolism.

30.Casdorph, H. R., " Hyperlipoproteinemia."  JAMA, Vol. 207:151  January 6, 1969.


31.Casdorph, H. R., "Current Concepts in the Treatment of the Hyperlipidemic States with Special Emphasis on the Place of Cholestyramine in Therapy."             Presented at the Fifteenth Annual Meeting, American College of Angiology at the        Dunes Hotel in Las Vegas Nevada, October 20-24, 1969.


32.Casdorph, H. R., Safe Uses of Cholestyramine."  Annals of Internal Medicine, Vol. 72: 759-760, May 1970.


33.Casdorph, H. R., Current Concept in the Recognition, Classification and Treatment of the Hyperlipidemic States."  Presented at the AMA Multidiscipline Research Forum, Convention of the American Medical Association held June 24, 1970.


34.Casdorph, H. R., "What's New in the Treatment of the Hyperlipidemic States." Presented at the Annual meeting of the American College of Cardiology, Waldorf Astoria in New York City, New York.


35.Casdorph, H. R., Current Concepts in the Classification and Treatment of the Hyperlipidemic States."   Presented  at  the  Twelfth  Annual  Meeting  of  the International College of Angiology in Dublin, Ireland on June 29-July 3, 1970.


36.Casdorph, H. R., Ed., Treatment of the Hyperlipidemic States."  Charles C. Thomas, Publisher, Springfield, 1971 (Medical Textbook).


37.Casdorph, H. R., Television Interview AMA, June 23, 1972 (closed network television system)  Annual Meeting of the American Medical Association, Chicago, Illinois.


38.Casdorph, H. R., "Hypercholesteremia: Scourge of Western Civilization"  Medical Counterpoint, Vol. 2, No. 11:12-22  November 1970.


39.Casdorph, H. R., "Lipid Determination in Xanthoma Patients." (letter), Modern Medicine, Vol. 38, No 14: 213 July 13, 1970.


40.Casdorph, H. R., Treatment of Hyperlipidemic States with Special Emphasis on the Place of Cholestyramine in Therapy."  Angiology Vol. 21, No. 10: 654-660 November 1970.


41.Casdorph, H. R., "Lipid Research and Dietary Relationships." Presented to the Long Beach Dieticians Study Group, February 16, 1971.


42.Casdorph, H. R.,   and Dayton, S.,.  Panel Discussion on  "Diet and Atherosclerosis," Internal Medicine Section of the California Medical Association Convention, Anaheim California March 13, 1971.


43.Casdorph, H. R., "The Efficacy and Safety of Cholestyramine Therapy in Hyperlipidemic Patients."  Presented at the Fifty Second Annual Session of the American College of Physicians in Denver, Colorado on March 18, 1971.


44.Casdorph, H. R., "Diet and Drugs Successfully Treat Hyperlipidemia." Modern Medicine, page 82, May 3, 1971.


45.Casdorph, H. R., "Management of the Excess Serum Lipid."  The New England Journal of Medicine, Vol. 284: 1103  May 13, 1971.


46.Casdorph, H. R., "Cholestyramine Preferred for Hyperlipidemia." Internal Medicine News, Vol. 4, page 7 May 15, 1971.


47.Casdorph, H. R., "Cholestyramine Normalizes Cholesterol." Chronic Disease Management, Vol. 5:8 May 1971.


48.Casdorph, H. R., "Value of Hypolipidemic Agent Held Confirmed by Long Study." Internist Observer, Vol. 9:5  June-July 1971.


49.Casdorph, H. R., "Cholestyramine Said to Reduce Serum Cholesterol, All Types." Medical Tribune and Medical News, Vol. 12:4  June 16, 1971.


50.Casdorph, H. R., The Aggressive Therapy of Type II Hyperlipidemia, (Familial Hypercholesteremia)."  Fourth International Symposium on Drugs Affecting Lipid Metabolism held in Philadelphia, Pennsylvania September 9, 1971.


51.Casdorph, H. R., Ausman, R., and Schmitz, T. H., "Evaluation of Dextrothyroxine in the Cardiac Patient." Fourth International Symposium on Drugs Affecting Lipid Metabolism held in Philadelphia, Pennsylvania September 9, 1971.


 52. Allen, W., Itano, N., Casdorph, H. R., "Recognition and Classification of Treatment of the Hyperlipidemic States."  Quarterly Staff Meeting of Memorial Hospital of Long Beach, California, September 14, 1971.


53.Casdorph, H.R., "Therapy of Hyperlipidemia".  Symposium:  Drugs in Heart Disease, Sponsored by the Long Beach Heart Association and Long Beach Pharmaceutical Association, Edgewater Hyatt House, September 19, 1971.


54.Casdorph, H. R., "The Efficacy and Safety of Cholestyramine Therapy in Hyperlipidemic Patients."  Abstract- Annals of Internal Medicine, Vol. 74, No. 5, p. 818.   May 1971.


55.Casdorph, H. R., The Aggressive Therapy of Type II Hyperlipidemia, (Familial Hypercholesteremia)".  Medical Tribune No. 45, Austrian edition, p. 30, 1971.


56.Casdorph, H. R., "Hyperlipidemias".  Presented to the Inyo Mono Medical Society Meeting on March 20, 1972.  Sugar and Spice Room at the Copper Kettle in Bishop, California.


57.Casdorph, H. R., "Normal Limits for Serum Cholesterol".  LANCET Vol.1: 1076, No. 759  May 13, 1972.


58.Casdorph, H. R., "Current Concepts in the Treatment of the Hyperlipidemic States".  Presented at the Fourteenth Annual Meeting of the International College of Angiology at the Royal College of Surgeons held in London, England on June 15, 1972.


59.Casdorph, H. R., "What You Eat Might Lead to Heart Disease". Memorial Mercury, Vol. 13, p. 30-31, Summer 1972.  Long Beach Memorial Hospital publication.


60.Casdorph, H. R., Site visit for National Heart and Lung Institute, Special Programs Branch to the University of Minnesota.  September 21-23, 1972. Surgical Control of the Hyperlipidemias.


61.Casdorph, H. R., The Place of Cholestryamine in the Hyperlipidemic States". 5th Asian Pacific Congress of Cardiology, Republic of Singapore, October 10, 1972.


62.Casdorph, H. R., and Connor, W. E.,  "Nutrition for Endurance Competition". JAMA Vol. 222, No. 8, November 20, 1972.


63.Casdorph, H. R., Abstract, "Hypertension and the Cardiovascular System: Review of Modern Medicine".  Published by Modern Medicine Publications, Minneapolis, Minnesota, 1972


64. Casdorph, H. R., "What You Can Do About the Coronary Epidemic". Presented before the "Mended Hearts Club" meeting at Memorial Hospital on January 9, 1973.


65.Casdorph, H. R., "The Heart Attack". Produced by Norman Siegel of CRM Education Films, Del Mar.  This 28 minute color film has won a gold medal at the International Film and Television Festival of New York City and a Golden Eagle Award (best category) in a Washington, DC Film Festival known as CINE, a Council on International Nontheatrical Events.  A follow-up called "The Heart Counterattack", was also shown on channel 28 (PBS) on January 26, 1973.


66.Casdorph, H. R., guest lectureship for Ayerst Laboratories, Inc. on "Classification and Treatment for the Hyperlipidemic States". Presented at the Thrifty Drug Store Headquarters Auditorium in Los Angeles.


67.Casdorph, H. R., "Ten Years Experience with Cholestyramine in the Treatment of Hyperlipidemias".  Third International Symposium on Atherosclerosis. West Berlin, Germany.  October 25-28, 1973.


68.Casdorph, H. R., "Review of Diagnosis and Treatment of Hyperlipidemic States". Presented before the Southern California Society of Hospital Pharmacists at St. Mary's Hospital, January 24, 1974.


69. Casdorph, H. R., "Lipids".  Presented before the Teacher's Symposium, sponsored by the Long Beach Heart Association at Long Beach Memorial Hospital on January 14, 1975.


70.Casdorph, H. R., "Familial Low Serum Cholesterol Levels in Obese Individuals". Questions and Answers JAMA, January 27, 1975.  Vol. 231, No. 4, p. 418.


 71.Connor, R. W., Connor, W. E., Wallace, R. B., Urban, M. C., Malinow, R. N., and Casdorph, H. R., "The Serum Lipids, Lipoproteins and Diet in the Tarahumara Indians of Mexico".  Abstract for conference on CVD epidemiology in Tampa, Florida  on March 10 and 11, 1975.


72.Casdorph, H. R., Azarnoff, D. L., Fredrickson, D. S., Hashim, S. A., Levy, R. J., "Meeting the Challenge of the Hyperlipidemics".  A monograph developed and produced by Health Learning Systems, Inc., Bloomfield, New Jersey under an educational grant from Mead Johnson Laboratories, Evansville, Indiana.


73.Casdorph, H. R., "The Single Dose Method of Administering Cholestyramine". Angiology, Vol. 26, No. 9.  October 1975.


74.Casdorph, H. R., "Cholestyramine and Ion Exchange Resin".  Lipid Pharmacology Paoletti, R. and Glueck, C. J. (Editors)  Academic Press        1976.


75.Casdorph, H. R., "Treatment of Familial Type II Hyperlipoproteinemia",  Questions and Answers in JAMA, April 26, 1976.  Vol. 235, No. 17, p. 1903. Edited by George X. Trimble, M.D.


76.Connor, W. E., Cerqueira, M. T., Connor, R. W., Wallace, R. B., Malinow, M. R., Casdorph, H. R., "The Plasma Lipids, Lipoproteins and Diet of the Tarahumara Indians of Mexico".  Am. J. of Clin. Nutrition 31: July 1978, p. 1131-1142.


77.Television taping for Cable Health Network with Pat Downey in conjunction with the 56th Annual Meeting of the American Heart Association, Anaheim Convention Center, November 15, 1983.


78. Expert Response to letter under "Questions and Answers" JAMA, February 22, 1985- 253:1185.


79. Rubin, M. , Rozema, T. , Casdorph, H.R. , Scarchilli, A., Cardiac decalcification by Na2MgEDTA.  Presented at the 208th meeting of the American Chemical   Society, August 21-25, 1994 in Washington, DC.  Paper presented by Dr. Martin          Rubin, Emeritus Professor of Biochemistry at Georgetown University.


80.February, 1995.  Casdorph, H.R. and Walker, M., Toxic Metal Syndrome, Avery Publishing Group, Garden City Park, New York, 1995.  413 pages.


 81.Invited speaker for the American Biologics 14th International Symposium on Integrative Medicine 2002. June 27-30. Rhodes, Greece. Speaking on the topic: “Seven Steps to Reversing Heart Disease” (Friday June 28, 2002).


82. Moderator of Hot Seat Panel, November 15, 2001, Long Beach Convention Center, ACAM fall meeting.


83.Casdorph, H.R., M.D., Real Miracles, Bridge-Logos Publishing Company, Gainesville, Florida, 2003. 199 pages.


84. Principal/ Site Investigator of the TACT study (Trial to Assess Chelation Therapy); a $30 million dollar randomized, double-blind study, which will enroll 2372 patients age 50 or older who have had a heart attack. The study is led by Gervasio A. Lamas, M.D., director of cardiovascular research and academic affairs at Mr. Sinai Medical Center at the Miami Heart Institute in Miami Beach, Florida. The study will test whether EDTA Chelation therapy and/or high dose of vitamin therapy is effective for the treatment of coronary artery disease and is funded by the National Institutes of Health. 2003.


85.Interview with Eugene Ellis, Esq. 1700 AM talk radio Controversial News Network, “The Miracle of Chelation Therapy”, Sunday, January 29, 2006 7-8 PM.





1.Guest speaker:  Fall Conference Orthomolecular and Preventive Medicine for the 80's.  October 5, 1980.  Topic:  Evaluation and Efficacy of Chelation Therapy Using Technetium 99m Radionucleid Flow Studies of the Brain and Heart Before and After the Administration of EDTA.


2. Address to Staff:  Long Beach Community Hospital Department of Internal Medicine  monthly  meeting.   Topic:   Medical  vs. Surgical  Treatment of Atherosclerosis:  Evaluation of Efficacy of Chelation Therapy in the Treatment of Atherosclerosis.  December 11, 1980.


3.Second Annual San Francisco Bay Area Seminar on Reversing the Aging Process which was spent along with Richard Passwater, Ph.D., Robert C. Atkins, M.D., Garry Gordon, M.D., Ross Gordon, M.D. on Sunday March 1, 1981 in Berkeley, California.


4."Chelation Therapy:  Effective Treatment of Cerebrovascular Disease"  presented July 2, 1981 at the International Symposium on Cerebrovascular Disease:  New Trends in Surgical and Medical Aspects at Gardone Riviera (Garda Lake, Italy). Meeting was held at the Villa Alba.


5."EDTA Chelation Therapy:  Efficacy in Arteriosclerotic Heart Disease". by H. R. Casdorph, M.D.  Journal of Holistic Medicine 1981.  3:53-59.


6. Guest speaker:  27th Annual Meeting of the National Health Federation.  January 23, 1982. Long Beach Convention Center.  Topic:  Progress in the Treatment of Cardiovascular Disease by Chelation Therapy.


7. "EDTA Chelation Therapy II:  Efficacy in Brain Disorders",  by H. R. Casdorph, M. D.  Journal of Holistic Medicine  Fall/ Winter 1981, 3:101-117.


8.Radio talk show interview on Chelation Therapy with Herb Nero, Station KKZZ. Taped June 16, 1982.  (805) 948-7521.


9.Radio interview KNX 1070 AM with host Jerry Laird on a program called Face to Face.  Alternate view presented by Dr. Raymond Schultze, Professor of Medicine and Nephrology, UCLA Hospital.  July 21, 1982. (460-3790)


10.Taping with Dale F. Batesole, KESQ-TV "There is a Way". August 11, 1982.


11."Chelation Therapy:  A Reappraisal", H. R. Casdorph, M.D., Ph.D.  New Zealand Medical Journal.  January 26, 1983 (Correspondence).


12.Taping with Dale F. Batesole, KESQ-TV, "There is a Way", December 16, 1982.  To be aired January 13, 1983 Channel 9, 7:30 AM.


13.Taping regarding Chelation Therapy for ACT organization, April 16, 1987.


14.Casdorph, H. R., "Alzheimer's Disease".  Let's Live Magazine.  May 1983, p. 16-22.


15.Taping with Imara Shaw July 8, 1983, "Feeling Good", to be shown July 30, 1983 on Group W Cable channel 3, 6:00 PM.


16."EDTA Chelation Therapy, Efficacy in Arteriosclerotic Heart Disease and Brain Disorders", by H. Richard Casdorph, M.D.   Journal of Chronic Disease and Therapeutic Research, 7: 105-115, 1983.


17.Taping of a program for Christian Cable Network with hostess Ms. Susan Stafford on December 11, 1983.  Audience of 22 million people.


18.Poster entitled "Magnesium/Calcium Ratio of Sublingual Cells in Patients With Alzheimer's Disease", presented at the poster session of the Third Annual Zurich Meeting of the International Study Group on the Treatment of Memory Disorders Associated with Aging held in Zurich, Switzerland.  January 13-15, 1984.


19.Casdorph, H. R. and Farr, C. H., "EDTA Chelation Therapy III:  Treatment of Peripheral Arterial Occlusion:  An Alternative to Amputation".  Journal of Holistic Medicine, Spring/Summer  1983.  Vol. 5, No. 1.


20.Foreword for the book "Bypassing Bypass", by Elmer M. Cranton, M.D. and Arlene Brecher.  Stein and Day, New York 1984.


21.Casdorph, H. R., "Objective Evidence of the Efficacy of EDTA Chelation Therapy in Patients with Heart Disease and Brain Disorders by Radionuclide Studies", presented at the Second International Symposium on Chelating Agents in Pharmacology, Toxicology and Therapeutics.  Pilsen, Czechoslovakia.  August 12-14, 1987.


22.Guest speaker at the Second International Symposium of Orthomolecular Medicine held at the Maksaud Plaza--Sao Paulo, Brazil.  Topic:  "Results of Chelation Therapy in Patients with Coronary Heart Disease".  September 22, 1989.


23.Guest Interview with Dr. Robert Atkins on Radio Station WOR in New York City on May 3, 1993.


24.Invited speaker for FAIM organization (Foundation for the Advancement of Innovative Medicine Education Fund Inc.)  Topic:  "Reversal of Coronary Atherosclerosis by EDTA Chelation Therapy."  Roosevelt Hotel, New York on June 5, 1993.  Speaking twice on June 5 to the general public and to the professional symposium on Complimentary Health Care.


25.February, 1995.  Casdorph, H.R. and Walker, M., Toxic Metal Syndrome, Avery Publishing Group, Garden City Park, New York, 1995.  413 pages.


26.July 1, 1999 Interview on “Doctor to Doctor” TV program for KTBN Channel 40 hosted by Dr. Pensanti, Costa Mesa, California. Viewed by 30 Million people.


27.Interview with George Putnam on KIEV AM Talk Radio on July 12, 2000.


28.Dr. Casdorph’s Seven Steps for Vigorous Health and Reversing Heart Disease presented to the Annual National Health Federation Meeting at the Pasadena Hilton, July 15, 2000.


29.Dr. Casdorph’s Seven Steps for Vigorous Health and Reversing Heart Disease presented to the Annual Health Federation Meeting at the Pasadena Hilton, February 18, 2001.


30.Invited speaker at the National Health Federation on the subject “Does Chelation Therapy Really Work” held at the Pasadena Hilton Hotel, March 16, 2002.


31.Invited speaker at the 14th International Symposium by American Biologics on the subject “7 steps to reversing heart disease” held on the island on Rhodes, Greece on June 28, 2002.


32. “ABC’s of Treating Heart Disease” – talk given taped at TBN (Trinity Broadcast Network) seen worldwide – at least 30 million people. February 26, 2004 – Broadcasted May 6, 2004.